A new study published in Genetics in Medicine examines how systemic barriers in health care shape Indigenous families’ views about genomic medicine in British Columbia. The research finds that physical and relational barriers to access, experiences of racism and persistent demands for self-advocacy impose resilience as a condition of care for Indigenous families.

Today, the Honourable Marjorie Michel, Minister of Health, announced that the Government of Canada and partners are investing over $41 million in groundbreaking cancer prevention research.

When Dr. Jennifer Ritonja joined BC Cancer in July 2025 as a scientist, she set out to advance how we detect and prevent cancer in women. A trained epidemiologist, her research focuses on identifying early indicators of cancer in women, particularly for breast and ovarian cancers. 

A pan-Canadian research team led by Dr. Helen McTaggart-Cowan, a BC Cancer scientist, will receive $183,500 through a new Patient Voices in Research Initiative from the Terry Fox Research Institute’s Marathon of Hope Cancer Centres Network (the Network) to examine barriers to accessing homologous recombination deficiency (HRD) testing for patients with advanced ovarian cancer.

In a new study, a team led by Dr. Dean Regier, Senior Scientist in Cancer Control at BC Cancer and co-chair of the MOHCCN Health Technology Assessment Working Group, conducted focus groups with individuals with lived and living experience with cancer to understand their values, expectations, and concerns for enhanced data sharing.

A BC Cancer-authored paper in the Canadian Association Medical Journal (CAMJ) has concluded that, with increased HPV screening rates, cervical cancer can be eliminated in Canada by almost a decade earlier than the federal government target of 2040.